Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
HKD 5.78
(0.0%)
HKD 5.78
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.09 Billion CNY | 10.33% |
| 2022 | 1.01 Billion CNY | 11.97% |
| 2021 | 840.2 Million CNY | 4.24% |
| 2020 | 856.78 Million CNY | 4.5% |
| 2019 | 781.33 Million CNY | 17.37% |
| 2018 | 667.23 Million CNY | 27.61% |
| 2017 | 604.38 Million CNY | 14.23% |
| 2016 | 479.47 Million CNY | 16.93% |
| 2015 | 382.62 Million CNY | -3.33% |
| 2014 | 323.98 Million CNY | 36.36% |
| 2013 | 243.41 Million CNY | 18.52% |
| 2012 | 250.92 Million CNY | -13.02% |
| 2011 | 255.66 Million CNY | 2.11% |
| 2010 | 270.34 Million CNY | 12.98% |
| 2009 | 261.02 Million CNY | 176.78% |
| 2008 | 99.1 Million CNY | -41.0% |
| 2007 | 58.79 Million CNY | 10.17% |
| 2006 | 152.52 Million CNY | 14.76% |
| 2005 | 132.86 Million CNY | 146.98% |
| 2004 | 53.79 Million CNY | -62.8% |
| 2003 | 144.59 Million CNY | -14.3% |
| 2002 | 168.71 Million CNY | -2.3% |
| 2001 | 172.68 Million CNY | 8.61% |
| 2000 | 158.99 Million CNY | 9.41% |
| 1999 | 145.31 Million CNY | 89.96% |
| 1998 | 76.49 Million CNY | -32.23% |
| 1997 | 112.88 Million CNY | -12.31% |
| 1996 | 128.73 Million CNY | 116.94% |
| 1995 | 59.33 Million CNY | -18.18% |
| 1994 | 72.52 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 99.8 Million CNY | -49.96% |
| 2024 Q1 | 177.07 Million CNY | 135.02% |
| 2024 Q2 | 199.42 Million CNY | -33.37% |
| 2023 Q4 | 127.34 Million CNY | 8.51% |
| 2023 Q2 | 203.78 Million CNY | 3.86% |
| 2023 FY | - CNY | 10.33% |
| 2023 Q3 | 117.35 Million CNY | -42.41% |
| 2023 Q1 | 196.19 Million CNY | 19.98% |
| 2022 Q1 | 144.01 Million CNY | 72.34% |
| 2022 Q4 | 163.52 Million CNY | 45.49% |
| 2022 Q3 | 112.39 Million CNY | -22.27% |
| 2022 FY | - CNY | 11.97% |
| 2022 Q2 | 144.6 Million CNY | 0.4% |
| 2021 Q3 | 92.15 Million CNY | -49.93% |
| 2021 Q1 | 143.06 Million CNY | 10.84% |
| 2021 Q2 | 184.05 Million CNY | 28.65% |
| 2021 Q4 | 83.56 Million CNY | -9.32% |
| 2021 FY | - CNY | 4.24% |
| 2020 Q4 | 129.06 Million CNY | 12.12% |
| 2020 Q1 | 129.1 Million CNY | -13.37% |
| 2020 FY | - CNY | 4.5% |
| 2020 Q3 | 115.11 Million CNY | -18.01% |
| 2020 Q2 | 140.4 Million CNY | 8.75% |
| 2019 Q2 | 121.63 Million CNY | 7.4% |
| 2019 FY | - CNY | 17.37% |
| 2019 Q1 | 113.24 Million CNY | -14.47% |
| 2019 Q3 | 131.83 Million CNY | 8.39% |
| 2019 Q4 | 149.03 Million CNY | 13.04% |
| 2018 Q2 | 88.95 Million CNY | -14.75% |
| 2018 Q3 | 105.01 Million CNY | 18.06% |
| 2018 FY | - CNY | 27.61% |
| 2018 Q1 | 104.35 Million CNY | 44.38% |
| 2018 Q4 | 132.4 Million CNY | 26.08% |
| 2017 Q3 | 67.73 Million CNY | -26.86% |
| 2017 Q1 | 74.45 Million CNY | -8.75% |
| 2017 Q2 | 92.59 Million CNY | 24.38% |
| 2017 FY | - CNY | 14.23% |
| 2017 Q4 | 72.27 Million CNY | 6.71% |
| 2016 FY | - CNY | 16.93% |
| 2016 Q3 | 64.55 Million CNY | 43.65% |
| 2016 Q2 | 44.93 Million CNY | -20.14% |
| 2016 Q1 | 56.27 Million CNY | -35.4% |
| 2016 Q4 | 81.59 Million CNY | 26.39% |
| 2015 FY | - CNY | -3.33% |
| 2015 Q1 | 42.46 Million CNY | -72.72% |
| 2015 Q4 | 87.11 Million CNY | 114.79% |
| 2015 Q3 | 40.55 Million CNY | -12.94% |
| 2015 Q2 | 46.58 Million CNY | 9.71% |
| 2014 Q3 | 33.43 Million CNY | -52.25% |
| 2014 Q4 | 155.64 Million CNY | 365.56% |
| 2014 FY | - CNY | 36.36% |
| 2014 Q1 | 19.97 Million CNY | -78.3% |
| 2014 Q2 | 70.01 Million CNY | 250.61% |
| 2013 Q1 | 11.3 Million CNY | -76.6% |
| 2013 Q3 | 16.64 Million CNY | -52.57% |
| 2013 FY | - CNY | 18.52% |
| 2013 Q4 | 92.04 Million CNY | 453.06% |
| 2013 Q2 | 35.08 Million CNY | 210.5% |
| 2012 Q3 | 12.62 Million CNY | -67.88% |
| 2012 Q2 | 39.3 Million CNY | 11.92% |
| 2012 FY | - CNY | -13.02% |
| 2012 Q1 | 35.11 Million CNY | -34.38% |
| 2012 Q4 | 48.29 Million CNY | 282.58% |
| 2011 Q4 | 53.51 Million CNY | 58.87% |
| 2011 Q1 | 47.82 Million CNY | -14.58% |
| 2011 Q2 | 43.67 Million CNY | -8.66% |
| 2011 Q3 | 33.68 Million CNY | -22.88% |
| 2011 FY | - CNY | 2.11% |
| 2010 Q3 | 50.31 Million CNY | 15.36% |
| 2010 FY | - CNY | 12.98% |
| 2010 Q1 | 39.59 Million CNY | -27.8% |
| 2010 Q2 | 43.61 Million CNY | 10.15% |
| 2010 Q4 | 55.98 Million CNY | 11.27% |
| 2009 Q3 | 38.49 Million CNY | 14.9% |
| 2009 Q2 | 33.5 Million CNY | 45.67% |
| 2009 FY | - CNY | 176.78% |
| 2009 Q1 | 22.99 Million CNY | -15.24% |
| 2009 Q4 | 54.83 Million CNY | 42.46% |
| 2008 FY | - CNY | -41.0% |
| 2008 Q4 | 27.13 Million CNY | 94.25% |
| 2008 Q3 | 13.96 Million CNY | -60.43% |
| 2008 Q2 | 35.29 Million CNY | 129.35% |
| 2008 Q1 | 15.38 Million CNY | 238.75% |
| 2007 Q2 | 19.15 Million CNY | 17.92% |
| 2007 Q1 | 16.24 Million CNY | -64.78% |
| 2007 FY | - CNY | 10.17% |
| 2007 Q4 | 4.54 Million CNY | -78.44% |
| 2007 Q3 | 21.06 Million CNY | 9.96% |
| 2006 Q4 | 46.13 Million CNY | 47.58% |
| 2006 Q3 | 31.25 Million CNY | -11.63% |
| 2006 Q2 | 35.37 Million CNY | -15.77% |
| 2006 FY | - CNY | 14.76% |
| 2006 Q1 | 41.99 Million CNY | 41.64% |
| 2005 Q2 | 39.15 Million CNY | -1.82% |
| 2005 Q4 | 29.64 Million CNY | 4.36% |
| 2005 Q3 | 28.4 Million CNY | -27.45% |
| 2005 FY | - CNY | 146.98% |
| 2005 Q1 | 39.88 Million CNY | 178.15% |
| 2004 Q3 | 24.71 Million CNY | -36.1% |
| 2004 Q1 | 49.39 Million CNY | 98.09% |
| 2004 FY | - CNY | -62.8% |
| 2004 Q2 | 38.67 Million CNY | -21.7% |
| 2004 Q4 | -51.03 Million CNY | -306.49% |
| 2003 FY | - CNY | -14.3% |
| 2003 Q3 | 29.03 Million CNY | -30.12% |
| 2003 Q2 | 41.54 Million CNY | -17.83% |
| 2003 Q1 | 50.56 Million CNY | 119.05% |
| 2003 Q4 | 24.93 Million CNY | -14.11% |
| 2002 Q2 | 25.36 Million CNY | -18.83% |
| 2002 Q1 | 31.25 Million CNY | 0.0% |
| 2002 Q3 | 15.48 Million CNY | -38.96% |
| 2002 Q4 | 23.08 Million CNY | 49.09% |
| 2002 FY | - CNY | -2.3% |
| 2001 FY | - CNY | 8.61% |
| 2000 FY | - CNY | 9.41% |
| 1999 FY | - CNY | 89.96% |
| 1998 FY | - CNY | -32.23% |
| 1997 FY | - CNY | -12.31% |
| 1996 FY | - CNY | 116.94% |
| 1995 FY | - CNY | -18.18% |
| 1994 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 150.4 Million HKD | -625.248% |
| Grand Pharmaceutical Group Limited | 2.96 Billion HKD | 63.231% |
| Extrawell Pharmaceutical Holdings Limited | -129.51 Million HKD | 942.165% |
| Wai Yuen Tong Medicine Holdings Limited | 113.79 Million HKD | -858.516% |
| Qianhai Health Holdings Limited | -50.22 Million HKD | 2271.599% |
| Lee's Pharmaceutical Holdings Limited | 109.82 Million HKD | -893.237% |
| Essex Bio-Technology Limited | 418.37 Million HKD | -160.715% |
| Tongfang Kontafarma Holdings Limited | 76.63 Million HKD | -1323.372% |
| PuraPharm Corporation Limited | -26.16 Million HKD | 4268.185% |
| SSY Group Limited | 2.11 Billion HKD | 48.416% |
| JBM (Healthcare) Limited | 204.39 Million HKD | -433.672% |
| Jacobson Pharma Corporation Limited | 429.92 Million HKD | -153.715% |
| China Resources Pharmaceutical Group Limited | 15.43 Billion HKD | 92.931% |